A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction

Authors:

Abstract
Significance: We are at an exciting era of identification of the cell and molecular processes necessary for tissue remodeling and repair. Unlike current systemic therapeutics, our studies reveal pharmacologic stimulation of SRCs modulates macrophage and fibrotic reparative cell responses to promote more effective repair and lasting beneficial remodeling after myocardial infarction.
Funding Information
  • Brockman Medical Res. Foundation (None)
  • BayerAG/Grants4Targets Initiative (2016-08-1815)
  • Cancer Center Support Grant (NCI-CA125123)
  • CPRIT Core Facilities Support Grant (RP170691)
  • NIH (HL 127717)
  • NIH (HL 130804)
  • NIH (HL 118761)
  • Vivien L. Smith Foundation and MacDonald Research Fund Award (16RDM001)
  • Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research (14CVD01)

This publication has 52 references indexed in Scilit: